Michael Roth, 10% Owner at Opexa Therapeutics, Inc. (OPXA), sold 629,876 shares at $0.25 ($145K) on 2008-09-22, disclosed to the SEC on 2008-09-23.
Open-market sale of $145k OPXA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.21 | 184,376 | $39K | 26.7% |
| 2 | $0.21 | 195,000 | $41K | 28.3% |
| 3 | $0.25 | 500 | $125 | 0.1% |
| 4 | $0.26 | 250,000 | $65K | 44.9% |
| Total | $0.23 avg | 629,876 | $145K | 100% |
| Filing → |
| LGBT | SELL | 2009-01-16 | $6K | — | Filing → |
| MFLX | SELL | 2008-06-30 | $2.0M | — | Filing → |
| MFLX | SELL | 2008-06-26 | $2.0M | — | Filing → |